Toky possesses expertise in bioinformatics and genomics, specializing in the application of IT and programming to enhance genomic research. 

His focus is on the integration of bioinformatics tools and machine learning for analyzing cancer genetics, notably microsatellite instability. Actively involved in research and development in oncology genomics, he demonstrates proficiency in high-throughput genomics, single-cell analysis, and leveraging deep learning for gene expression analysis.

His research aims at improving the predictability of treatment responses in colorectal and breast cancer, striving to identify novel biomarkers and facilitate biological interpretations of AI models. 

His work was awarded by the « Pépite » national contest and the French Society of Personalized Medicine. 

In 2022, he co-founded MSInsight and acts as Chief Technical Officer.

Sydney Normand is the Chief of Staff at MSInsight, where she leads strategic operations, internal coordination, and cross-functional projects to support the company’s growth. With a background in critical care nursing, Sydney earned her nursing degree in the United States and spent two years working in intensive care before transitioning to the healthtech sector.

She recently completed her Master’s in Health Management and Data Intelligence at EMLyon, where she combines her clinical insight with business strategy. At MSInsight, she plays a key role in company communications, investor relations, and high-level project management, working closely with leadership to advance precision oncology solutions.

Prior to joining MSInsight, Sydney lived and worked in the U.S., Brazil, and now France, giving her a global outlook on healthcare and innovation. Outside of work, she enjoys hiking, CrossFit, and training her whippet puppy, Thimble, (in French). She is passionate about building relationships and believes in the power of teamwork, faith, and mission-driven work to create real impact.

As Tech Lead at MSInsight, Seif bridges the gap between innovation and implementation. He oversees the development of the MSICare platform, manages sprint planning, and ensures alignment between technical delivery and business goals. A graduate of Esprit School of Engineering with a specialization in Project Portfolio Management, Seif previously worked across Europe as a Software Engineer before transitioning into project leadership roles, where he led SaaS deployments in the logistics and telecom sectors. He brings a strong background in full-stack development, cloud technologies, and agile methodologies. At MSInsight, Seif coordinates a multidisciplinary development team, drives the Scrum process, and supports strategic product decisions alongside the CTO. His goal is to scale MSInsight’s technology to empower personalized oncology care. Outside of work, Seif is passionate about AI, fitness, and building tech-driven solutions that improve everyday life.

Mathieu is a junior full-stack developer at MSInsight, working on the development of our platform from frontend design to cloud infrastructure and algorithm integration. He holds a full-stack developer degree from IT-Akademy and specializes in creating seamless, scalable systems that bridge user experience and backend performance. His role spans R&D and operations, contributing to both the technical foundation and the continuous evolution of our product. He is especially passionate about clean code, efficient architecture, and solving real-world problems through tech. Outside of work, Mathieu enjoys open-source projects, self-hosted tools, and exploring new digital solutions.

Sati serves as a Junior Full-Stack Developer at MSInsight, where she designs user interfaces, deploys cloud services and integrates algorithmic components. After earning her specialist diploma in Marketing from SPbGEU and spending several years in the marketing field, she sharpened her technical expertise by completing a Full-Stack program at IT-Akademy. Sati’s professional focus lies in crafting robust, scalable applications—tackling both front-end and back-end challenges with an emphasis on clean code and well-considered architecture. In her free time, she competes in hackathons, builds personal learning projects and explores cutting-edge methods for optimizing the development process.

As Quality Assurance and Regulatory Affairs (QARA) Engineer at MSInsight, Mélyna ensures the company’s Quality Management System remains compliant with ISO 13485 and oversees the technical documentation for all in vitro diagnostic (IVD) products developed by the team. She plays a key role in maintaining regulatory compliance and supporting product development from a quality and safety perspective.

Mélyna holds an engineering degree in the biomedical field from ISIFC (Institut Supérieur d’Ingénieurs de Franche-Comté), which underpins her multidisciplinary approach combining life sciences, technology, and regulatory strategy. Her expertise helps bridge innovation and compliance in the highly regulated IVD space.

At MSInsight, she focuses on aligning internal processes with IVDR requirements, leading audits, and promoting a culture of continuous improvement. Outside of work, Mélyna is passionate about cooking and enjoys exploring new recipes in her free time.

Balthazar is an engineer in bioinformatic at MSInsight. He possesses an engineering degree in data science with a specialization in bioinformatics from EFREI Paris and another engineering degree in biology from EBI. After a M2 internship at CRSA in the team of Alex Duval, he has joined MSInsight to apply his knowledge in computer science and genomics. In July, he will start a CIFRE thesis at MSInsight in collaboration with the CRSA and the SCAI to develop a tool for the detection of MSI in cancer with NGS data using deep learning.

Alex is a full professor of medicine at Sorbonne University, specialized in Cancer Genetics. He has been directing an Inserm team for over 18 years in Paris with research activity dedicated to MSI cancers. 

As a medical doctor, he heads the MSI precision medicine cancer diagnostics laboratory at the La Pitié-Salpêtrière Hospital, Paris. He is an internationally recognized opinion leader regarding the personalized care of these tumors. Translational genomic research activities aim at discovering new risk factors, biomarkers, and diagnostic tools, some of which have been patented, licensed, and used in routine clinics.

He has over 120 publications and 10 patents. 

At MSInsight, he is in charge of our scientific programs.

Within Paris Hospital, Florence is an anatomopathologist specialized in MSI diagnosis. Her scientific interests lie in digestive oncology, digestive pathology, molecular biology, and digital pathology. She also holds a position as an associate professor at Sorbonne University. 

At MSInsight, she plays a key role in shaping the company’s medical strategy.

Luc Marchand is a licensed pharmacist and long-time healthcare entrepreneur. A graduate of the Université Paris-Saclay (Faculty of Pharmacy, Industrial Option) and the IAE Lyon School of Management, Luc has managed his own pharmacy within the Maison Médicale de Dommartin (Rhône) since 1997.

He is an active member of the Totum pharmacy network and serves as the lead pharmacist for the group’s product development efforts. As one of MSInsight’s earliest shareholders, Luc brings a practitioner’s perspective and hands-on knowledge of the healthcare system to the company’s strategic discussions.

His dual expertise in pharmaceutical operations and business development supports MSInsight’s mission to bring innovative diagnostics closer to patients and providers.

Gérard Der Agobian is a seasoned executive with extensive experience in strategic governance and financial oversight. As a member of MSInsight’s Strategic Board, he contributes deep business acumen and a pragmatic, investor-oriented perspective to company growth and long-term planning.

With a strong track record in guiding startups through key financial milestones, Gérard plays an active role in reviewing operational performance, supporting strategic decisions, and helping ensure sound governance practices. His insight and support are instrumental as MSInsight navigates funding rounds, organizational scaling, and innovation in precision oncology.

Dr. Sébastien Giraudier is an entrepreneur and life sciences innovator with a PhD in Biochemistry and Biophysics and an MBA from HEC. He currently serves as Director of Neighborhood at Voisin Consulting Life Sciences (VCLS), where he supports healthcare startups with strategic guidance and mentorship.

A former CTO at AMM Tech, Sébastien led the repositioning of a molecule for a rare pediatric disease through a successful Phase 3 trial and European marketing approval. He also founded a medical device company in 2007, raising over €4 million. At MSInsight, he brings two decades of experience in medtech, regulatory strategy, and biotech innovation.

Sébastien is deeply involved in the TechBio movement, with a focus on AI and digital technologies in healthcare, and co-leads the healthcare group at Hub France IA.

Sébastien Tabruyn holds a PhD in Molecular Biology and brings over two decades of experience in immunology, oncology, and translational research. He currently serves as CEO of TransCure BioServices, a contract research organization specializing in humanized mouse models for preclinical drug development.

With a career at the intersection of scientific innovation and executive leadership, Sébastien offers MSInsight strategic guidance informed by deep domain knowledge and a clear understanding of the biotech landscape. His contributions at the board level reflect a rigorous, science-first mindset and a commitment to advancing precision medicine.

Alain Charroux has spent his entire professional career in the software industry and brings over 20 years of expertise in Machine Learning and Artificial Intelligence. As a representative of Y-Invest, Alain supports MSInsight as a Strategic Board Advisor, providing thoughtful guidance on software engineering challenges.

His collaborative and humble approach makes him a valuable asset to the MSInsight team, offering insights that bridge technical depth with strategic vision. Alain’s long-standing experience in cutting-edge software development strengthens MSInsight’s commitment to innovation in precision oncology.

Outside of his formal role, Alain brings energy and curiosity to every conversation—traits that were evident even during his PhD years, which he humorously refers to as his « Ravachol/Kropotkin phase. »

Please note: Any public mention of Y-Invest in association with Alain’s role is subject to validation by the Y-Invest team.